The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects
Clinical trial NCT05166837 · COMPLETED
Trial details
- NCT number
- NCT05166837
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2023-01-12
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.